Evidence map›Paper›PMID 39861420›Full record

ArticleNutrients2025

Effect of

Kenji Gonda, Takeshi Hai, Kouichi Suzuki, Akihiko Ozaki, Takashi Shibusa, Seiichi Takenoshita, Yuko Maejima, Kenjyu Shimomura

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Creeping fig (Frontiers in pharmacology · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kenji GondaDepartment of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City 972-8322, Fukushima, Japan.ORCID 0000-0002-7671-1808
Takeshi HaiDepartment of Internal Medicine, Daido Central Hospital, 1-1-37 Asato, Naha City 902-0067, Okinawa, Japan.
Kouichi SuzukiDepartment of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan.
Akihiko OzakiDepartment of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City 972-8322, Fukushima, Japan.ORCID 0000-0003-4415-9657
Takashi ShibusaDepartment of Internal Medicine, Jyoban Hospital of Tokiwa Foundation, Iwaki City 972-8322, Fukushima, Japan.
Seiichi TakenoshitaDepartment of Drug Research for Astatine-221 Targeted Alfa Therapy, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan.
Yuko MaejimaDepartment of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan.
Kenjyu ShimomuraDepartment of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: It has been reported that people affected by COVID-19, an infectious disease caused by SARS-CoV-2, suffer from various diseases, after infection. One of the most serious problems is the increased risk of developing diabetes after COVID-19 infection. However, a treatment for post-COVID-19 infection diabetes has not yet been established. In this study, we investigated the effects of

Indexed as

COVID-19Diabetes MellitusFicusInsulinInsulin ResistanceInsulin SecretionPlant ExtractsAged, 80 and overBlood GlucoseFemaleHumansMaleSARS-CoV-2Blood GlucoseInsulinPlant ExtractsCOVID-19diabetes mellitusFicus pumila L.HOMA-IRHOMA-β

Identifiers

PMID39861420
PMCPMC11767592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.